Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| Whole-blood total chromium and DNA repair variation in an occupational Cr(VI)-exposure setting: Pathway-resolved associations across complementary response biomarkers. | J Hazard Mater | 2026 | 42772066 | PubTator, text mining | PubMed |
| Distinct functions of mammalian RAD51 paralogs in genome maintenance. | Biochem Soc Trans | 2026 | 42682019 | PubTator, text mining | PubMed |
| Impact of Multigene Panel Testing in High-Risk Uveal Melanoma Patients. | Pigment Cell Melanoma Res | 2026 | 42415513 | PubTator, text mining | PubMed |
| Saturation Genome Editing reveals the functional impact of RAD51D and XRCC2 variants. | bioRxiv | 2026 | 42327150 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and Pesticide Exposure-Related Health Manifestations Among Grape Farmers in Maharashtra, India. | Cureus | 2026 | 42281721 | PubTator, text mining | PubMed |
| Particulate Hexavalent Chromium Inhibits RAD51 Paralogs Necessary for RAD51 Filament Formation and Stabilization During Homologous Recombination Repair. | Occup Health (Auckl) | 2026 | 42169974 | PubTator, text mining | PubMed |
| The Homozygous p.(Arg215Ter) Variant in XRCC2 Is Associated With Atypical Fanconi Anemia Without Major Hematological Abnormalities in Childhood. | Am J Med Genet A | 2026 | 42071175 | PubTator, text mining | PubMed |
| The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways. | Nucleic Acids Res | 2026 | 42055550 | PubTator, text mining | PubMed |
| Oxidative Stress, DNA Damage, DNA Repair Inhibition, and Apoptosis Induced by Lead and Cadmium Combined Exposure in TK6 Cells. | Toxics | 2026 | 42043168 | PubTator, text mining | PubMed |
| Structural insight into how RAD51 paralog exchange regulates RAD51 filament formation. | Nat Struct Mol Biol | 2026 | 42020761 | PubTator, text mining | PubMed |
| Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients. | Mol Oncol | 2026 | 41885368 | PubTator, text mining | PubMed |
| CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia. | Neoplasia | 2026 | 41844049 | PubTator, text mining | PubMed |
| Identification of a biologically coherent three gene immune signature predictive of immunotherapy benefit in gastric adenocarcinoma. | Discov Oncol | 2026 | 41832372 | PubTator, text mining | PubMed |
| KAT2B-mediated epigenetic suppression of RAD51C enhances olaparib sensitivity in colorectal cancer. | Cancer Chemother Pharmacol | 2026 | 41826541 | PubTator, text mining | PubMed |
Computational identification of rare pathogenic genomic variants in esophageal cancer markers: Transcript-level analysis, sequence-based insights, and structural-functional impacts of non-synonymous SNPs. | Biochem Biophys Rep | 2026 | 41777455 | PubTator, text mining | PubMed |
| BCDX2-CX3 and DX2-CX3 complexes assemble and stabilize RAD51 filaments. | Nature | 2026 | 41772053 | PubTator, text mining | PubMed |
| Increasing the Response of Mismatch Repair Proficient Rectal Cancer to Immunotherapy with Particle Radiation and DNA Damage Response Inhibitors-Preclinical Evidence. | Cancers (Basel) | 2026 | 41749935 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer. | Proc Natl Acad Sci U S A | 2026 | 41591905 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers